DRAXIS Health Reports Fourth Quarter and Year E...(ucceed; - the volatility of the pri...),Health

- the volatility of the price of our common shares;

- market acceptance of the Company's products;

- factors described under "Outlook and Guidance Intentions" above and

the Company's MD&A for the quarter ended December 31, 2007; and

- the risks described in "Item 3. Key Information - Risk Factors" in

the Annual Report Form 20-F filed by the Company with the United

States Securities and Exchange Commission and which is also filed as

the Company's Annual Information Form with Canadian securities

regulators.

For additional information with respect to certain of these and other factors, and relating to the Company generally, reference is made to the Company's most recent filings with the United States Securities and Exchange Commission (available on EDGAR at http://www.sec.gov) and the filings made by the Company with Canadian securities regulators (available on SEDAR at http://www.sedar.com). The forward-looking statements contained in this document represent the Company's expectations as at February 6, 2008. Unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

DRAXIS HEALTH INC.

Consolidated Statements of Operations

In Accordance with U.S. GAAP

-------------------------------------------------------------------------

(in thousands of U.S. dollars except share related data)

(unaudited)

For the Three-Month Periods For the Years

Ended December 31, Ended December 31,

--------------------------- -----------------------

2007 2006
'/>"/>